A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Mise à jour : Il y a 4 ans
Référence : NCT01034410

Femme et Homme

Extrait

This is an open label randomized controlled phase II study of AS1411 combined with Cytarabine in the treatment of patients with primary refractory or relapsed acute myeloid leukemia.


Critère d'inclusion

  • Acute Myeloid Leukemia


Liens